Skip to main content
. 2017 Apr 9;58(7):1315–1324. doi: 10.1194/jlr.M073882

Fig. 2.

Fig. 2.

Cholesterol (A) and apoB-100 (B) concentrations in lbLDL and sdLDL during the placebo and rosuvastatin 40 mg/day phases. Data are expressed as mean ± SEM (n = 6). White bar, placebo phase; shaded bar, rosuvastatin phase.